Hattori Y - Search Results

1

A patient with genetic deletion of glutathione-S-transferase T1 and M1 who developed non-small-cell lung cancer and myelodysplastic syndromes.

Arai Y, Hirose N, Yamamura K, Nagai M, Jang H, Hattori Y, Ikeda Y. Arai Y, et al. Among authors: hattori y. Am J Med Sci. 1999 Dec;318(6):424-7. doi: 10.1097/00000441-199912000-00011. Am J Med Sci. 1999. PMID: 10616169

2

Restoration of retinoid sensitivity by MDR1 ribozymes in retinoic acid-resistant myeloid leukemic cells.

Matsushita H, Kizaki M, Kobayashi H, Ueno H, Muto A, Takayama N, Awaya N, Kinjo K, Hattori Y, Ikeda Y. Matsushita H, et al. Among authors: hattori y. Blood. 1998 Apr 1;91(7):2452-8. Blood. 1998. PMID: 9516145 Free article.

3

[Natural killer-like T-cell lymphoma appearing in the duodenum with recurrence in a variety of extranodal organs].

Tsuzuki Y, Okamoto S, Takayama N, Kamata T, Hattori Y, Kawai Y, Kizaki M, Ikeda Y. Tsuzuki Y, et al. Among authors: hattori y. Rinsho Ketsueki. 1999 Jun;40(6):494-8. Rinsho Ketsueki. 1999. PMID: 10422287 Japanese.

4

Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3.

Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y, Koseki T, Nishihara T, Ikeda Y. Kawamura C, et al. Among authors: hattori y. Blood. 2000 Sep 15;96(6):2005-11. Blood. 2000. PMID: 10979940 Free article.

5

[Follicular lymphoma in two brothers].

Asahi A, Okamoto S, Matsushita H, Hattori Y, Takayama N, Ikeda Y. Asahi A, et al. Among authors: hattori y. Rinsho Ketsueki. 2001 May;42(5):408-13. Rinsho Ketsueki. 2001. PMID: 11452461 Review. Japanese.

6

Keratinocyte growth factor regulates proliferation and differentiation of hematopoietic cells expressing the receptor gene K-sam.

Kamata T, Hattori Y, Hamada H, Kizaki M, Terada M, Ikeda Y. Kamata T, et al. Among authors: hattori y. Exp Hematol. 2002 Apr;30(4):297-305. doi: 10.1016/s0301-472x(01)00800-1. Exp Hematol. 2002. PMID: 11937263 Free article.

7

Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity.

Sato N, Hattori Y, Wenlin D, Yamada T, Kamata T, Kakimoto T, Okamoto S, Kawamura C, Kizaki M, Shimada N, Ote Y, Hata J, Ikeda Y. Sato N, et al. Among authors: hattori y. Jpn J Cancer Res. 2002 Apr;93(4):459-66. doi: 10.1111/j.1349-7006.2002.tb01278.x. Jpn J Cancer Res. 2002. PMID: 11985797 Free PMC article.

8

Thalidomide for the treatment of refractory multiple myeloma: association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcome.

Kakimoto T, Hattori Y, Okamoto S, Sato N, Kamata T, Yamaguchi M, Morita K, Yamada T, Takayama N, Uchida H, Shimada N, Tanigawara Y, Ikeda Y. Kakimoto T, et al. Among authors: hattori y. Jpn J Cancer Res. 2002 Sep;93(9):1029-36. doi: 10.1111/j.1349-7006.2002.tb02480.x. Jpn J Cancer Res. 2002. PMID: 12359057 Free PMC article.

9

Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.

Du W, Hattori Y, Hashiguchi A, Kondoh K, Hozumi N, Ikeda Y, Sakamoto M, Hata J, Yamada T. Du W, et al. Among authors: hattori y. Pathol Int. 2004 May;54(5):285-94. doi: 10.1111/j.1440-1827.2004.01622.x. Pathol Int. 2004. PMID: 15086832

10

Thalidomide-induced severe neutropenia during treatment of multiple myeloma.

Hattori Y, Kakimoto T, Okamoto S, Sato N, Ikeda Y. Hattori Y, et al. Int J Hematol. 2004 Apr;79(3):283-8. doi: 10.1532/ijh97.03136. Int J Hematol. 2004. PMID: 15168599 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,196 results

Search Page

Filters